Strategies to Improve Prescribing in Heart Failure Patients
Strategies To Improve Appropriate Prescribing In Heart Failure Patients. Assessment of the Effectiveness of an Integrated Clinical Pathway Between Cardiology and Primary Care Physicians to Implement Pharmacological Treatment
Sponsor: Associazione Nazionale Medici Cardiologi Ospedalieri
Terminated
Up to sponsor decision
Other terminated trials from Associazione Nazionale Medici Cardiologi Ospedalieri
- Acute Decompensated Heart Failure · Phase PHASE4 · Apr 2017
- Acute Coronary Syndrome · Phase PHASE3 · Apr 2007
More terminations from Associazione Nazionale Medici Cardiologi Ospedalieri
This NA trial investigates Chronic Heart Failure and is currently terminated or withdrawn. Associazione Nazionale Medici Cardiologi Ospedalieri leads this study, which shows 9 recorded versions since 2010 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jul 2018 — Jan 2021 [monthly]
Terminated NA
Status: Suspended → Terminated
▶ Show 4 earlier versions
-
Jun 2018 — Jul 2018 [monthly]
Suspended NA
-
May 2017 — Jun 2018 [monthly]
Suspended NA
-
Apr 2017 — May 2017 [monthly]
Suspended NA
-
Jan 2017 — Apr 2017 [monthly]
Suspended NA
First recorded
Jan 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Associazione Nazionale Medici Cardiologi Ospedalieri
- National Centre for Disease Prevention and Control
- Niguarda Hospital
For direct contact, visit the study record on ClinicalTrials.gov .